Cargando…

Nivolumab dose selection: challenges, opportunities and lessons learned for cancer immunotherapy

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Agrawal, Shruti, Feng, Yan, Roy, Amit, Kollia, Georgia, Lestini, Brian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645268/ http://dx.doi.org/10.1186/2051-1426-3-S2-P141

Ejemplares similares

Nivolumab dose selection: challenges, opportunities, and lessons learned for cancer immunotherapy
por: Agrawal, Shruti, et al.
Publicado: (2016)

Quantitative Characterization of the Exposure–Response Relationship for Cancer Immunotherapy: A Case Study of Nivolumab in Patients With Advanced Melanoma
por: Wang, X, et al.
Publicado: (2016)

Role of dose selection in successful interleukin-2 immunotherapy: solving the Goldilock’s Complex
por: Zloza, Andrew, et al.
Publicado: (2013)

Pre-treatment patient selection for nivolumab benefit based on serum mass spectra
por: Weber, Jeffrey, et al.
Publicado: (2015)

Hand hygiene improvement in Nigeria: challenges and opportunities
por: Kama-Kieghe, S, et al.
Publicado: (2015)

Identification of continued challenges and opportunities in oncologists' comprehension of immuno-oncology
por: Herrmann, Tara, et al.
Publicado: (2015)

Complications of sequential immunotherapy in metastatic melanoma
por: Bufalino, Shams, et al.
Publicado: (2015)

Recruitment challenges in surgical trials: lessons from the crisp trial
por: Pike, K, et al.
Publicado: (2013)

A poetic story: lessons learnt from the world's largest breast cancer window of opportunity study
por: Bliss, Judith, et al.
Publicado: (2015)

Current clinical challenges and opportunities in oncologists' familiarity and understanding of immuno-oncology
por: Herrmann, Tara, et al.
Publicado: (2014)

Subset analysis of the safety and efficacy of nivolumab in elderly patients with metastatic melanoma
por: Freeman, Morganna, et al.
Publicado: (2015)

P40 - Double-blind, placebo-controlled, food challenges (DBPCFC) of a strong tasting food: lessons learned
por: Borschel, Marlene, et al.
Publicado: (2014)

NP-114: Lesson Learned: Management of patients with Multiple Myeloma (MM) and their response to two doses of COVID-19 RNA vaccine
por: Verina, Daniel, et al.
Publicado: (2021)

Immunotherapy generates selective pressure for acquisition of immunogenic neoantigens in escape tumors
por: Pan, Jenny H, et al.
Publicado: (2015)

Stable disease, diagnosis and dose are prognostic factors for survival after interleukin-2 immunotherapy
por: Kwan, Nathan H, et al.
Publicado: (2015)

Lessons learnt and challenges in adopting the ECDC and who Ebola guidelines at Mater Dei Hospital
por: Abela, N, et al.
Publicado: (2015)

P279: Infection prevention and control program in developing countries: achievements, challenges and opportunities in Cambodia
por: Sok, S, et al.
Publicado: (2013)

Managing norovirus outbreaks: opportunities for organisational learning
por: Murray, EJ, et al.
Publicado: (2011)

Recruiting schools, adolescents and parents to a sexual-health trial: experiences, challenges and lessons learned from the Jack Trial (NCT02092480)
por: Aventin, Aine, et al.
Publicado: (2015)

Markers of inflammation are associated with clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab
por: Sznol, Mario, et al.
Publicado: (2015)

A Phase III study (CheckMate 238) of adjuvant immunotherapy with nivolumab (NIVO) versus ipilimumab (IPI) after complete resection of stage IIIb/c or stage IV melanoma (MEL) in patients (pts) at high risk for recurrence
por: Weber, Jeffrey, et al.
Publicado: (2015)

Cell-selective oligonucleotide STAT3 inhibitor for immunotherapy of human acute myeloid leukemia
por: Zhang, Qifang, et al.
Publicado: (2015)

Immunotherapy with patient-specific antigens selection reduced the metastasis of a cervical cancer patient
por: Han, Yanyan, et al.
Publicado: (2015)

The challenges of using radiological ‘tumour response' as an outcome: lessons learned from neo-tango and artemis, two neo-adjuvant chemotherapy breast cancer trials
por: Hiller, Louise, et al.
Publicado: (2013)

An open label randomized Phase III trial of nivolumab or nivolumab plus ipilimumab vs platinum doublet chemotherapy (PT-DC) in patients with chemotherapy-naïve stage IV or recurrent non-small cell lung cancer (NSCLC) (CheckMate 227)
por: Hellmann, Matthew, et al.
Publicado: (2015)

Recruitment to the pilot phase of Start2quit – lessons learned
por: Gardner, Leanne M, et al.
Publicado: (2011)

Characterisation of hepatobiliary lesions in an African referral hospital: initial MDCT dose challenges
por: Mutala, TM, et al.
Publicado: (2015)

Learning as you go: an audit of continuing professional development opportunities in the workplace
por: Richards, Katrina
Publicado: (2011)

Poster 1000: Efficacy and safety of specific sublingual immunotherapy with carbamylated allergoid tablets of ragweed pollen: a dose-ranging study
por: Compalati, Enrico, et al.
Publicado: (2014)

Are there lessons to learn from review of false-negative assessment interval cancers?
por: Sharma, N, et al.
Publicado: (2006)

Tumor-induced suppressive CD8+ T cells: implications for cancer immunotherapy
por: Pfannenstiel, Lukas W, et al.
Publicado: (2013)

Development of novel combinations of targeted and immunotherapies by understanding immune resistance using a high throughput assay of T cell mediated cytotoxicity
por: Malu, Shruti, et al.
Publicado: (2013)

Identification of novel immune checkpoints as targets for cancer immunotherapy
por: Rotman, Galit, et al.
Publicado: (2013)

High-dose treatment with ADXS11-001, a listeria monocytogenes (Lm)-listeriolysin O (LLO) immunotherapy, in women with cervical cancer
por: Ghamande, Sharad, et al.
Publicado: (2015)

Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032
por: Taylor, Matthew, et al.
Publicado: (2015)

Definition of aspirin resistance using whole blood impedance aggregometry in patients undergoing coronary artery surgery: methodological challenges and outcome improvement opportunities
por: Petricevic, M, et al.
Publicado: (2013)

Cancer nanomedicine meets immunotherapy: opportunities and challenges
por: Sun, Qingxue, et al.
Publicado: (2020)

Harnessing the potential of radiation treatment of brain metastases to improve melanoma immunotherapy
por: McNeilly, Corey D, et al.
Publicado: (2015)

P063: Tackling VRE in a community hospital with teamwork and tenacity: lessons learned
por: Raggiunti, P, et al.
Publicado: (2013)

P05-02 Implementing exercise based injury prevention programs -lessons learned
por: Nauta, Joske
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5n16eqtp0ld4j0e4e9ud4o3o5c